This topic contains a solution. Click here to go to the answer

Author Question: Who might be most at risk for an infectious disease? A. The woman who has been taking ... (Read 72 times)

dollx

  • Hero Member
  • *****
  • Posts: 558
Who might be most at risk for an infectious disease?
 
  A. The woman who has been taking antituberculosis (TB) medication for 3 months
  B. The 85-year-old woman who recently emigrated with her much younger family from Asia and currently spends her days in an unlicensed senior day care center
  C. A full-time nurse at the local public health clinic
  D. A volunteer nurse aide at the STD clinic

Question 2

For what infection are health care professionals particularly at risk?
 
  A. Drug-resistant salmonella
  B. HBV
  C. MDR-TB
  D. STDs, including AIDS



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

randomguy133

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

ANS: B

Answer to Question 2

ANS: B





 

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library